Kindstar Globalgene Technology, Inc. is an investment holding company that provides clinical testing services in the People's Republic of China and Mainland China. It operates through nine segments: Hematology Testing, Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, Routine Testing, CROs and R&D Project, and Others. The company offers esoteric testing services for hematology, oncology, neuroscience, and infectious diseases, and is also involved in product development and technical services, reagent development and sales, CAR-T treatment, and e-commerce services. Its research and development projects include molecular biology detection, flow cytometry detection, cytogenetic detection, and pathological detection technologies. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, the People's Republic of China.